Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure that affects the left side of the heart. It occurs when the lower left chamber of the heart, called the left ventricle ...

A review indicates obesity may amplify pathophysiology in HFrEF rather than acting as a primary cause, though weight loss data remain inconclusive.

A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the ...

Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection ...

Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

Finerenone was associated with a 16% reduction for the primary composite endpoint of cardiovascular death and total HF events compared with placebo. The Food and Drug Administration (FDA) has accepted ...

LV myocardial strain reference values from CT reveal sex differences in healthy adults. Learn how this could refine cardiac ...

Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.